Avanos Medical, Inc. (AVNS)
NYSE: AVNS · IEX Real-Time Price · USD
27.99
-0.36 (-1.27%)
Mar 23, 2023, 4:00 PM EDT - Market closed
Income Statement (Annual)
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Year | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 - 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 820 | 744.6 | 714.8 | 697.6 | 652.3 | 611.6 | 566.2 | 509 | 1,672.1 | 1,677.5 | |
| Revenue Growth (YoY) | 10.13% | 4.17% | 2.47% | 6.94% | 6.65% | 8.02% | 11.24% | -69.56% | -0.32% | -0.39% | |
| Cost of Revenue | 370 | 378.8 | 343.9 | 295.4 | 261.4 | 274.7 | 269 | 251.2 | 1,123.5 | 1,065.3 | |
| Gross Profit | 450 | 365.8 | 370.9 | 402.2 | 390.9 | 336.9 | 297.2 | 257.8 | 548.6 | 612.2 | |
| Selling, General & Admin | 341.9 | 300.3 | 332.6 | 399.1 | 340.4 | 321.7 | 346.2 | 349.7 | 424.5 | 351.4 | |
| Research & Development | 30.6 | 32.3 | 34.9 | 37.7 | 41.8 | 38.2 | 38.4 | 27.6 | 33.6 | 37.9 | |
| Operating Expenses | 372.5 | 332.6 | 367.5 | 436.8 | 382.2 | 359.9 | 384.6 | 377.3 | 458.1 | 389.3 | |
| Operating Income | 77.5 | 33.2 | 3.4 | -34.6 | 8.7 | -23 | -87.4 | -119.5 | 90.5 | 222.9 | |
| Interest Expense / Income | 10 | 3.3 | 15.6 | 15 | 26.4 | 31.6 | 32.7 | 33.1 | 6 | 0.1 | |
| Other Expense / Income | 2.3 | 22.6 | 50.7 | 14.4 | -65.6 | -93.8 | -104 | 341 | -6.7 | -5 | |
| Pretax Income | 65.2 | 7.3 | -62.9 | -64 | 47.9 | 39.2 | -16.1 | -493.6 | 91.2 | 227.8 | |
| Income Tax | 14.7 | 1 | -33.9 | -18.1 | -9.6 | -40.1 | -55.9 | -67.3 | 64.1 | 73.2 | |
| Net Income | 50.5 | 6.3 | -29 | -45.9 | 57.5 | 79.3 | 39.8 | -426.3 | 27.1 | 154.6 | |
| Net Income Growth | 701.59% | - | - | - | -27.49% | 99.25% | - | - | -82.47% | 1.31% | |
| Shares Outstanding (Basic) | 46 | 48 | 48 | 48 | 47 | 47 | 47 | 47 | 47 | 47 | |
| Shares Change | -3.51% | 0.74% | -0.20% | 1.06% | 1.26% | 0.35% | 0.13% | 0.17% | - | - | |
| EPS (Basic) | 1.08 | 0.13 | -0.61 | -0.96 | 1.22 | 1.69 | 0.85 | -9.15 | 0.58 | 3.32 | |
| EPS (Diluted) | 1.07 | 0.13 | -0.61 | -0.96 | 1.22 | 1.69 | 0.85 | -9.15 | 0.58 | 3.32 | |
| EPS Growth | 723.08% | - | - | - | -27.81% | 98.82% | - | - | -82.53% | 1.22% | |
| Free Cash Flow Per Share | 1.54 | 1.38 | -0.47 | -2.61 | -4.11 | 2.16 | 3.49 | 0.75 | 1.66 | 3.76 | |
| Gross Margin | 54.88% | 49.13% | 51.89% | 57.65% | 59.93% | 55.09% | 52.49% | 50.65% | 32.81% | 36.49% | |
| Operating Margin | 9.45% | 4.46% | 0.48% | -4.96% | 1.33% | -3.76% | -15.44% | -23.48% | 5.41% | 13.29% | |
| Profit Margin | 6.16% | 0.85% | -4.06% | -6.58% | 8.81% | 12.97% | 7.03% | -83.75% | 1.62% | 9.22% | |
| Free Cash Flow Margin | 8.73% | 8.90% | -3.18% | -17.93% | -29.85% | 16.53% | 28.77% | 6.88% | 4.62% | 10.44% | |
| Effective Tax Rate | 22.55% | 13.70% | - | - | -20.04% | -102.30% | - | - | 70.29% | 32.13% | |
| EBITDA | 122.9 | 48.9 | -4.4 | -12.1 | 107.8 | 130.3 | 81.8 | -395.1 | 182.6 | 297.1 | |
| EBITDA Margin | 14.99% | 6.57% | -0.62% | -1.73% | 16.53% | 21.30% | 14.45% | -77.62% | 10.92% | 17.71% | |
| Depreciation & Amortization | 47.7 | 38.3 | 42.9 | 36.9 | 33.5 | 59.5 | 65.2 | 65.4 | 85.4 | 69.2 | |
| EBIT | 75.2 | 10.6 | -47.3 | -49 | 74.3 | 70.8 | 16.6 | -460.5 | 97.2 | 227.9 | |
| EBIT Margin | 9.17% | 1.42% | -6.62% | -7.02% | 11.39% | 11.58% | 2.93% | -90.47% | 5.81% | 13.59% |
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).